Prescription drug company Omnicare Inc. agreed to an $8 million settlement this week to end a whistleblower claim that accused it of falsely billing Medicare and Medicaid in 28 states for a different drug than actually dispensed.
The false claims allegedly generated by the scheme ran into the billions of dollars, according to a 66-page lawsuit filed in U.S. District Court in New Jersey in February 2014. The suit was filed under the False Claims Act.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
